以色列IceCure Medical公司获得欧洲专利, Israeli company IceCure Medical gets European patent nod for tumor-freezing tech, boosting stock.

以色列医疗技术公司IceCure Medical已经收到欧洲专利局的通知,打算通知其低温系统连接器,这是其肿瘤冻结技术的一部分。 Israeli medical tech company IceCure Medical has received an intention to grant notice from the European Patent Office for its Cryogenic System Connector, a part of its tumor-freezing technology. 该系统已经在美国获得专利,旨在改善安全并降低外科手术风险。 The system, already patented in the US, aims to improve safety and reduce surgical risks. 这一消息导致冰库股票价值略有上升。 This news led to a slight rise in IceCure's stock value. 全球肿瘤消融市场（包括 IceCure 的技术）价值 16.7 亿美元。 The global tumor ablation market, including IceCure's technology, is valued at $1.67 billion.